Castleman disease – clinical case report
Keywords:
atypical lymphoproliferative disease, corticotherapy, Castleman’s diseaseAbstract
Castleman’s disease (CD) is an atypical lymphoproliferative
disease that affects B cells and in which we can distinguish 3
variants. Its approach is different according to the presenting
form: solitary or multicentric.
The authors present a clinical case of multicentric CD, plasma
cell variant, in a patient not infected by human immunodeficiency
virus. Based on the case, the authors make a revision of the
literature concerning this disease.
Downloads
References
Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph node hyperplasia. Cancer 1956; 9:822-830.
Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978; 6: 86-90.
Cacoub P, Raphael M, Bolcert F, Wechsier B, Blétry O, Chomette G, Godeau P. Qui se cache derriére la maladie de Castleman multicentrique? A propos de 11 observations. Rév Med Interne 1991; 12: 77S.
Leger-Ravet MD, Penchmantz M, Devergne O et al. Interleukin 6 gene expression in Castleman’s disease. Blood 1992; 78: 2923-2930.
Du MQ, Liu H, Diss TC. Kaposi sarcoma-associated herpes virus infects monotypic but polyclonal naive B cells in Castleman´s disease and associated lymphoproliferative disorders. Blood 2001; 97: 2130-2136
Oksenhendler E, Duarte M, Soulier J. Multicentric Castleman disease in HIV infection: a clinical and pathological study of 20 patients. AIDS 1996 Jan; 10 (1): 61-67.
Sarrot-Reynauld F, Cacoub P et le Group Français d´Etude de La Maladie de Castleman. Maladie de Castleman: étude préliminaire d’une cohort nationale de 67 cas. Rev Med Interne 1998; 19: 413S.
HerradeJ, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman disease. Ann Int Med 1998; 128: 657-662.
Frizzera G. Castleman’s disease and related disorders. Semin Diagn Path 1998; 5: 346-364.
Bowne B, Lewis J. The management of Unicentric and Multicentric Castleman’s Disease. A Report of 16 Cases and Review of the Literature. American Cancer Society. Cancer 1999; 85: 706-717.
Beck JT, HSU SM, Wijdenes J, Bataille R, Klein B, Vesole D et al. Brief report: alleviation of systemic manifestations of Castleman’s disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 1994; 330: 602-605.
Herrada J, Cabanillas F. Multicentric Castleman’s disease. Am J Clin Oncol 1995; 18: 180-183
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
